176 related articles for article (PubMed ID: 28403675)
1. Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer.
Van Schil PE; Yogeswaran K; Hendriks JM; Lauwers P; Faivre-Finn C
Expert Rev Anticancer Ther; 2017 Jun; 17(6):555-561. PubMed ID: 28403675
[TBL] [Abstract][Full Text] [Related]
2. Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer.
Bograd AJ; Vallières E
Semin Respir Crit Care Med; 2020 Jun; 41(3):346-353. PubMed ID: 32450588
[TBL] [Abstract][Full Text] [Related]
3. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
4. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
Xu YP; Li B; Xu XL; Mao WM
Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
[TBL] [Abstract][Full Text] [Related]
5. Surgical Management of Stage IIIA Non-Small Cell Lung Cancer.
Van Schil PE; Berzenji L; Yogeswaran SK; Hendriks JM; Lauwers P
Front Oncol; 2017; 7():249. PubMed ID: 29124039
[TBL] [Abstract][Full Text] [Related]
6. Role of surgery in N2 NSCLC: pros.
Shien K; Toyooka S
Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
[TBL] [Abstract][Full Text] [Related]
7. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Ramnath N; Dilling TJ; Harris LJ; Kim AW; Michaud GC; Balekian AA; Diekemper R; Detterbeck FC; Arenberg DA
Chest; 2013 May; 143(5 Suppl):e314S-e340S. PubMed ID: 23649445
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
9. Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy.
Voltolini L; Luzzi L; Ghiribelli C; Paladini P; Di Bisceglie M; Gotti G
Eur J Cardiothorac Surg; 2001 Dec; 20(6):1106-12. PubMed ID: 11717012
[TBL] [Abstract][Full Text] [Related]
10. Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group.
Vansteenkiste J; De Leyn P; Deneffe G; Menten J; Lerut T; Demedts M
Eur J Cardiothorac Surg; 1998 Jan; 13(1):1-12. PubMed ID: 9504724
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of multi-level N2-positive non-small cell lung cancer according to lymph node staging using endobronchial ultrasound-transbronchial biopsy.
Yoon HY; Lee JC; Kim SW; Kim HR; Kim YH; Choi SH; Kim SS; Song SY; Choi EK; Jang SJ; Choi CM
Thorac Cancer; 2018 Jun; 9(6):684-692. PubMed ID: 29607613
[TBL] [Abstract][Full Text] [Related]
12. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
13. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
Veeramachaneni NK; Feins RH; Stephenson BJ; Edwards LJ; Fernandez FG
Ann Thorac Surg; 2012 Sep; 94(3):922-6; discussion 926-8. PubMed ID: 22742842
[TBL] [Abstract][Full Text] [Related]
14. Current status of induction treatment for N2-Stage III non-small cell lung cancer.
Yamaguchi M; Sugio K
Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):651-9. PubMed ID: 25355643
[TBL] [Abstract][Full Text] [Related]
15. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).
Robinson LA; Ruckdeschel JC; Wagner H; Stevens CW;
Chest; 2007 Sep; 132(3 Suppl):243S-265S. PubMed ID: 17873172
[TBL] [Abstract][Full Text] [Related]
16. Treatment of stage IIIA non-small cell lung cancer.
Robinson LA; Wagner H; Ruckdeschel JC;
Chest; 2003 Jan; 123(1 Suppl):202S-220S. PubMed ID: 12527580
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy for stage IIIa non-small cell lung cancer.
Fossella FV; Rivera E; Roth JA
Curr Opin Oncol; 1996 Mar; 8(2):106-11. PubMed ID: 8727302
[TBL] [Abstract][Full Text] [Related]
18. [Review on Treatment Modalities for Resectable IIIa/N2 Non-small Cell Lung Cancer].
Xu Z; Xing P; Ma D; Zhu Y; Ying J; Li J
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):111-117. PubMed ID: 30827328
[TBL] [Abstract][Full Text] [Related]
19. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
[TBL] [Abstract][Full Text] [Related]
20. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
